Have questions? Visit https://www.reddit.com/r/SNPedia

23andMe

From SNPedia
Revision as of 17:55, 5 March 2008 by Cariaso (talk | contribs)

wikipedia:23andMe

23andMe is a private biotech company based in the USA.

In 2007, they began offering direct-to-consumer genetic testing. Their service uses a customized Illumina Hap550+ array.

23andMe customers may be interested in using the Personal Genome Explorer and Promethease to learn more about their own dna.


Here is a list of all of the SNPedia snps on the customized chip

Older posts (from 2007) related to the (extensive) press coverage received by 23andMe:

You can watch the founders explain their plan during this youtube video.

Blog coverage has been extensive, you will find more information at bbgm

According to a story in Fortune, Warren Buffet and Jimmy Buffet submitted DNA tests for 23andMe. Approximately March 2007. Fortune Magazine June 11 2007

NY Times biography of Anne Wojcicki

NY Times coverage of 23andMe

a well written analysis of 23andMed from bioarraynews (login req)

Bio-IT World has announced the three keynote speakers for its sixth annual Bio-IT World Conference & Expo, to be held in Boston April 28-30, 2008).

The keynoters will be Linda Avey, co-founder of 23andMe; Joshua Boger, president & CEO of Vertex Pharmaceuticals; and John Reynders, CIO, Johnson & Johnson Life Sciences Division.

Linda Avey is the co-founder of 23andMe, the Bay Area consumer genomics start-up. She previously worked in sales and business development for Affymetrix and Perlegen Sciences. Prior to that, Avey had stints at Spotfire and Applied Biosystems. Avey founded 23andMe with Anne Wojcicki, wife of Google co-founder Sergey Brin (Google is also an investor in 23andMe). Partnering with Illumina, 23andMe will shortly unveil a consumer genotyping service offering individuals whole-genome analysis to learn about genealogy, ancestry, and medical issues. Avey will speak on Wednesday morning, April 30, 2008.

Various news sites reported on Oct-4-2007 23andMe had raised an additional $9 million in funding. investor include Google, Mohr Davidow Ventures, New Enterprise Associates, and Genentech.

genomeboy found a few new details on 23andMe and Navigenics

photos from Flickr..